QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 miRNA-mRNA regulatory network analysis of mesenchymal stem cell treatment in cisplatin-induced acute kidney injury identifies roles for miR-210/Serpine1 and miR-378/Fos in regulating inflammation 期刊论文 MOLECULAR MEDICINE REPORTS, 2019, 卷号: 20, 期号: 2 作者:  Ma, Piyong;  Zhang, Chunmei;  Zhao, Zhongyan;  Jiang, Nan;  Lian, Dede 收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05 cisplatin  acute kidney injury  mesenchymal stem cells  microRNAs  connectivity map  small molecule drugs   Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas 期刊论文 MOLECULAR NEUROBIOLOGY, 2016, 卷号: 53, 期号: 4 作者:  Gao, Yufei;  Ma, Piyong;  He, Yichun;  Liu, Yan;  Jiang, Yang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Astrocytomas  KDR  Single nucleotide polymorphisms  Genetic association  Haplotype   Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome 期刊论文 ONCOLOGY LETTERS, 2016, 卷号: 12, 期号: 3 作者:  Zhou, Changyu;  Li, Jiayu;  Li, Jiarui;  Wan, Yingchun;  Li, Tao 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Lynch syndrome  differentially expressed miRNA  target gene  regulatory network   Gene expression profiling of CD133-positive cells in coronary artery disease 期刊论文 MOLECULAR MEDICINE REPORTS, 2015, 卷号: 12, 期号: 5 作者:  Sang, Haiyan;  Li, Jiayu;  Zhou, Changyu;  Li, Jiarui;  Wan, Yingchun 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 coronary artery disease  gene expression profiles  differentially expressed genes  functional enrichment analysis  small molecules   Therapeutic potential of intravenous Xuebijing on transforming growth factor beta(1) and procollagen type III peptide in patients with acute paraquat poisoning 期刊论文 JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2012, 卷号: 32, 期号: 4 作者:  Sun, Xiaoli;  Zheng, Xuebing;  Liu, Zhongming;  Jiang, Nan;  Ma, Piyong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Paraquat  Poisoning  Receptors  transforming growth factor beta  Peptides  Xuebijing  intravenous